Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China
· Delayed Price · Currency is CNY 26.02
+0.08 (0.31%)
At close: Jun 11, 2025, 2:57 PM CST
SHA:688739 Market Cap
SHA:688739 has a market cap or net worth of 10.57 billion as of June 13, 2025. Its market cap has decreased by -9.78% in one year.
Market Cap
10.57B
Enterprise Value
5.18B
Revenue
1.67B
Ranking
n/a
PE Ratio
31.67
Stock Price
26.02
Market Cap Chart
Since October 28, 2021, SHA:688739's market cap has decreased from 33.32B to 10.57B, a decrease of -68.28%. That is a compound annual growth rate of -27.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 10.57B | -0.43% |
| Dec 31, 2024 | 10.61B | -21.62% |
| Dec 29, 2023 | 13.54B | 6.87% |
| Dec 30, 2022 | 12.67B | -60.04% |
| Dec 31, 2021 | 31.70B | -4.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 369.84B |
| Shenzhen Mindray Bio-Medical Electronics | 286.14B |
| WuXi AppTec | 195.03B |
| Sichuan Biokin Pharmaceutical | 135.34B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.36B |
| Aier Eye Hospital Group | 113.59B |
| Shanghai United Imaging Healthcare | 108.35B |
| Yunnan Baiyao Group Co.,Ltd | 101.72B |